Disruption of Dag1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration

Cell

Volumn 110, Issue 5, 2002, Pages 639-648

  Cohn, Ronald D ^a   Henry, Michael D ^a   Michele, Daniel E ^a   Barresi, Rita ^a   Saito, Fumiaki ^a   Moore, Steven A ^a   Flanagan, Jason D ^a   Skwarchuk, Mark W ^b   Robbins, Michael E ^b   Mendell, Jerry R ^c   Williamson, Roger A ^a   Campbell, Kevin P ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROGLYCAN; DYSTROPHIN; GLYCOPROTEIN; PROTEIN; PROTEIN DAG1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; MOUSE; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; SATELLITE CELL; SKELETAL MUSCLE;

ANIMALIA;

EID: 18644362893     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(02)00907-8     Document Type: Article

References (28)

1. Alderton J.M., Steinhardt R.A. How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. Trends Cardiovasc. Med. 10:2000;268-272.
2. Brockington M., Yuva Y., Prandini P., Brown S.C., Torelli S., Benson M.A., Herrmann R., Anderson L.V., Bashir R., Burgunder J.M.et al. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum. Mol. Genet. 10:2001;2851-2859.
3. Bruning J.C., Michael M.D., Winnay J.N., Hayashi T., Horsch D., Accili D., Goodyear L.J., Kahn C.R. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell. 2:1998;559-569.
4. Bushby K.M. Genetics and the muscular dystrophies. Dev. Med. Child Neurol. 42:2000;780-784.
5. Cohn R.D., Campbell K.P. The molecular basis of muscular dystrophy. Muscle Nerve. 23:2000;1456-1471.
6. Coral-Vazquez R., Cohn R.D., Moore S.A., Hill J.A., Weiss R.M., Davisson R.L., Straub V., Barresi R., Bansal D., Hrstka R.F.et al. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle. a novel mechanism for cardiomyopathy and muscular dystrophy Cell. 98:1999;465-474.
7. Cossu G., Mavilio F. Myogenic stem cells for the therapy of primary myopathies. wishful thinking or therapeutic perspective? J. Clin. Invest. 105:2000;1669-1674.
8. Cote P.D., Moukhles H., Lindenbaum M., Carbonetto S. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat. Genet. 23:1999;338-342.
9. Durbeej M., Cohn R.D., Moore S.A., Hrstka R.F., Allamand V., Davidson B.L., Williamson R., Campbell K.P. Disruption of the β-sarcoglycan gene reveals a complex pathogenetic mechansim for LGMD 2E. Mol. Cell. 5:2000;141-151.
10. Ervasti J.M., Ohlendieck K., Kahl S.D., Gaver M.G., Campbell K.P. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature. 345:1990;315-319.
11. Ferrari G., Cusella-De Angelis G., Coletta M., Paolucci E., Stornaiuolo A., Cossu G., Mavilio F. Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 279:1998;1528-1530.
12. Garry D.J., Meeson A., Elterman J., Zhao Y., Yang P., Bassel-Duby R., Williams R.S. Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF. Proc. Natl. Acad. Sci. USA. 97:2000;5416-5421.
13. Gu H., Marth J.D., Orban P.C., Mossmann H., Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science. 265:1994;103-106.
14. Gussoni E., Soneoka Y., Strickland C.D., Buzney E.A., Khan M.K., Flint A.F., Kunkel L.M., Mulligan R.C. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 401:1999;390-394.
15. Henry M.D., Campbell K.P. A role for dystroglycan in basement membrane assembly. Cell. 95:1998;859-870.
16. Henry M.D., Campbell K.P. Dystroglycan inside and out. Curr. Opin. Cell Biol. 11:1999;602-607.
17. Heslop L., Morgan J.E., Partridge T.A. Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J. Cell Sci. 113:2000;2299-2308.
18. Ibraghimov-Beskrovnaya O., Ervasti J.M., Leveille C.J., Slaughter C.A., Sernett S.W., Campbell K.P. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 355:1992;696-702.
19. Irintchev A., Zeschnigk M., Starzinski-Powitz A., Wernig A. Expression pattern of M-cadherin in normal, denervated, and regenerating mouse muscles. Dev. Dyn. 199:1994;326-337.
20. Kong J., Anderson J.E. Dynamic restoration of dystrophin to dystrophin-deficient myotubes. Muscle Nerve. 24:2001;77-88.
21. Michele D.E., Barresi R., Kanagawa M., Saito F., Cohn R.D., Satz J.S., Dollar J., Nishino I., Kelley R.I., Somer H.et al. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophy. Nature. 418:2002;417-421.
22. Moore S.A., Saito F., Chen J., Michele D.E., Henry M.D., Messing A., Cohn R.D., Ross-Barta S.E., Westra S., Williamson R.A.et al. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature. 418:2002;422-425.
23. Mussini I., Sogos V., Della Barbera M., Ennas M.G., Gremo F. Immunolocalisation of dystrophin in the immature human neurons and muscles. Ital. J. Anat. Embryol. 100(Suppl 1):1995;155-163.
24. Potocnik A.J., Brakebusch C., Fassler R. Fetal and adult hematopoietic stem cells require beta1 integrin function for colonizing fetal liver, spleen, and bone marrow. Immunity. 6:2000;653-663.
25. Sunada Y., Bernier S.M., Kozak C.A., Yamada Y., Campbell K.P. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J. Biol. Chem. 269:1994;13729-13732.
26. Tallquist M.D., Soriano P. Epiblast-restricted Cre expression in MORE mice. a tool to distinguish embryonic vs. extra-embryonic gene function Genesis. 26:2000;113-115.
27. Williamson R.A., Henry M.D., Daniels K.J., Hrstka R.F., Lee J.C., Sunada Y., Ibraghimov-Beskrovnaya O., Campbell K.P. Dystroglycan is essential for early embryonic development. disruption of Reichert's membrane in Dag1-null mice Hum. Mol. Genet. 6:1997;831-841.
28. Winder S.J. The membrane-cytoskeleton interface. the role of dystrophin and utrophin J. Muscle Res. Cell Motil. 18:1997;617-629.